Valiant Laboratories Limited - Company Profile

Q: Who are the current directors of Valiant Laboratories Limited?

The current directors of Valiant Laboratories Limited are Velji Karamshi Gogri, Paresh Shashikant Shah, Shantilal Shivji Vora, Prajakta Kantishwar Patil, Sandeep Gupta, Sonal Amit Vira, Ashok Lakhamshi Chheda, Santosh Shantilal Vora, Mulesh Manilal Savla, Akshay Dnyaneshwar Gangurde.

It is a pharma public limited company based in Mumbai, Maharashtra, India, established in 2021.

2021 Mumbai, Maharashtra, India Active

Last Updated: January 05, 2026

Access Report

About Valiant Laboratories Limited

Valiant Laboratories Limited, a active public limited company, was established on 16 August 2021 in Mumbai, Maharashtra, India. Engaging in api manufacturers within the manufacturing sector, it holds CIN: L24299MH2021PLC365904. Registered under ROC Roc Mumbai. it is listed. It has an authorized capital of ₹60.00 Cr and a paid-up capital of ₹54.31 Cr.

It upholds a compliant status. In 2023, it reported revenue of ₹338.77 Cr and a net worth of ₹100.49 Cr. Employing 77 professional, Its leadership includes Velji Karamshi Gogri (Director), Paresh Shashikant Shah (Whole-Time Director), Shantilal Shivji Vora (Director). Past directors included Velji Karamshi Gogri, Paresh Shashikant Shah, Shantilal Shivji Vora. It holds ₹62.40 Cr open charges and ₹52.00 Cr settled loans. Its latest AGM occurred on 25 September 2025, with the balance sheet filed on 31 March 2025. It is based at 104,Udyog Kshetra,Mulundgoregoanlinkroad Mulund West, Mumbai, Maharashtra, 400080.

Company Details

CIN/LLPIN
L24299MH2021PLC365904
Registration Number
365904
Incorporation Date
16 August 2021
Authorized Capital
₹60.00 Cr
Paid-Up Capital
₹54.31 Cr
ROC Code
Roc Mumbai
Listing Status
Listed
Company Status
Active

Key Metrics

Authorised Capital ₹ 60.00 Cr as on 05-01-2026
Paid Up Capital ₹ 54.31 Cr as on 05-01-2026
Company Age 4 Year, 6 Months
Last Filing with ROC 31 Mar 2025
Open Charges ₹ 62.40 Cr as on 05-01-2026
Satisfied Charges ₹ 52.00 Cr as on 05-01-2026
Revenue Growth **** 61.39% (FY 2023)
Profit Growth **** 27.66% (FY 2023)
Ebitda **** 16.37% (FY 2023)
Net Worth 40.62% (FY 2023)
Total Assets **** 21.99% (FY 2023)

Comprehensive Company Insights

Explore comprehensive insights into Valiant Laboratories Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report

Who are the key members and board of directors at Valiant Laboratories Limited?

Current Directors

Name	Designation	Appointment Date	Status
Velji Karamshi Gogri	Director	06 Feb 2022	Current
Paresh Shashikant Shah	Whole-Time Director	16 Aug 2021	Current
Shantilal Shivji Vora	Director	16 Aug 2021	Current
Sandeep Gupta	Director	23 Feb 2023	Current
Sonal Amit Vira	Director	16 Feb 2022	Current
Ashok Lakhamshi Chheda	Director	12 Nov 2024	Current

Past Directors

Name	Designation	Cessation	Status
Pramod Abcsdd	Additional Director	21 Feb 2022	Past
Pramod Abcsdd	Director	24 Sep 2025	Past
Pramod Abcsdd	Director	20 Feb 2022	Past
Pramod Abcsdd	Company Secretary	-	Past
Pramod Abcsdd	Additional Director	12 Sep 2023	Past
Pramod Abcsdd	Additional Director	21 Feb 2022	Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Valiant Laboratories.

Valiant Laboratories Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 61.39% increase. The company also saw a substantial improvement in profitability, with a 27.66% increase in profit. The company's net worth Soared by an impressive increase of 40.62%.

Date	Amount	Transaction Name	Valuation	Lead Investors	Investors
Jul, 2021	Amount	Post-IPO - Grab	Valuation	investors	Emtek
Feb, 2021	Amount	Post-IPO - Grab	Valuation	investors	Signite Partners
Jan, 2021	Amount	Post-IPO - Grab	Valuation	investors	Hana Financial Group , GGV Capital
Feb, 2021	Amount	Post-IPO - Grab	Valuation	investors	Signite Partners

Upgrade Required

Full access to Financial is available only for users with an active Premium plan.

Key Matrics
Balance Sheet
Profit and Loss
Cash Flow
Ratios

Metrics

(FY 2023)

YOY Growth

(FY 2022)

(FY 2021)

(FY 2020)

(FY 2019)

Total Revenue

********

61.39%

*******

Revenue from Operations

*******

60.35%

*******

Total Assets

*******

21.99%

*******

Profit or Loss

*******

27.66%

*******

Net Worth

*******

40.62%

*******

EBITDA

*******

16.37%

*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Valiant Laboratories?

In 2024, Valiant Laboratories had a promoter holding of 61.84% and a public holding of 38.16%. The company had 1 Subsidiary. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)

Promoters: 92.83%
Public: 4.10%
Others: 3.07%

Shareholding Pattern over the Year

	FY (2024)	FY (2023)	FY (2022)	FY (2021)	FY (2020)
Promoters	92.83	94.62	94.55	94.55	94.55
Public	4.10	3.89	3.95	3.96	3.98
Others	3.07	1.49	1.50	1.49	1.47

Upgrade Required

Full access to Ownership and Shareholding Structure is available only for users with an active Premium plan.

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)

Open Charges

₹624,000,000.00

Satisfied Charges

₹520,000,000.00

Charges Breakdown by Lending Institutions

Others : 52.00 Cr
The Hongkong And Shanghai Banking Corporation Limited : 10.40 Cr

Latest Charge Details

Date	Lender	Amount	Status
29 May 2025	The Hongkong And Shanghai Banking Corporation Limited	₹1.00 Cr	Open
08 Jun 2024	The Hongkong And Shanghai Banking Corporation Limited	₹4.40 Cr	Open
28 Feb 2024	The Hongkong And Shanghai Banking Corporation Limited	₹5.00 Cr	Open
23 Sep 2022	Others	₹52.00 Cr	Open
14 Oct 2022	Others	₹52.00 Cr	Satisfied

Explore comprehensive loan charge details -

How Many Employees Work at Valiant Laboratories?

Valiant Laboratories has a workforce of 77 employees as of Apr 08, 2025. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee Date	Number of Employees
2020	78,000
2021	80,500
2022	83,200
2023	86,000
2024	89,500
2025	92,000

Upgrade Required

Full access to People is available only for users with an active Premium plan.

Deals i

Gain comprehensive insights into the Deals and Valuation data of Valiant Laboratories, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Valiant Laboratories's trajectory.

Rating

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Valiant Laboratories

Recent Activity within the Organization

Annual General Meeting

The activity Valiant Laboratories Limited last Annual general meeting of members was held on 25 Sep 2025 as per latest MCA records. was completed.
25 Sep 2025
Charges

The activity A charge with Others of Rs. 52.00 Cr registered on 23 Sep 2022 with Charge ID 100617061 was modified on 04 Sep 2025. was completed.
04 Sep 2025
Director Appointment

Progress on Akshay Dnyaneshwar Gangurde was appointed as a Company Secretary was appointed as a Company Secretary on 17 Jul 2025 & has been associated with this company since 7 months 15 days . was documented.
17 Jul 2025
Charges

A charge with The Hongkong And Shanghai Banking Corporation Limited amounted to Rs. 1.00 Cr with Charge ID 101111471 was registered on 29 May 2025. was recorded as a recent event.
29 May 2025
Balance Sheet

Valiant Laboratories Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Mumbai. was recorded as a recent event.
31 Mar 2025
Director Appointment

The activity Ashok Lakhamshi Chheda was appointed as a Director was appointed as a Director on 12 Nov 2024 & has been associated with this company since 1 year 3 months . was completed.
12 Nov 2024

Explore recent activity and updates - View Recent Activity